NCT05842109View on ClinicalTrials.gov

Clinical Value of ETCOc in the Diagnosis and Treatment of ABO-HDN

RecruitingOBSERVATIONAL

Enrollment

112

Participants

Timeline

Start Date

October 31, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2026

Conditions

ABO Hemolytic Disease of Newborn

Trial Locations (1)

Unknown

RECRUITING

Women's hospital School of medicine Zhejiang University, Hangzhou

All Listed Sponsors

lead

Women's Hospital School Of Medicine Zhejiang University

OTHER